Nearly 40 years ago, UCSF scientists ushered in the era of type 1 diabetes prevention. UCSF Diabetes Center is now working to solve the biggest challenges standing between patients and functional cures for the disease.

This year marks our 25th Anniversary and a quarter century of science aimed at saving lives and revolutionizing what the world thought possible in diabetes prevention and care. Our director Mark Anderson sits down with senior science writer and UCSF News Laura López González to discuss what the future may hold, including a functional cure. 

Our panel of UCSF experts explore the root causes of excess weight, how weight-loss drugs work, and their potential for transforming care for people with obesity and diabetes, delving into these emerging new therapies for what they mean for the future of the field, including the pioneering concept of precision nutrition.

When mice with atopic dermatitis—a common type of allergic skin inflammation—are treated with drugs that target the immune system, their thickened, itchy skin generally heals quickly.

We are learning how immune cells naturally clear the body of senescent cells that contribute to aging and many chronic diseases. Understanding this process may open new ways of treating age-related chronic diseases with immunotherapy.

New technologies in the effort to discover a cure for type 1 diabetes include figuring out how to rewire the immune system by transplanting islets from donors.

Featuring speakers Julie Sneddon, UCSF, and Everett Meyer, Stanford; a special thanks goes out to Michelle Griffin and Karen Jordan.

For over a half century, UCSF researchers and clinicians have been making breakthrough discoveries that have improved diabetes treatment and care for individuals with diabetes and their families. Ten years ago, a new, comprehensive Diabetes Center was created that united the research, clinical care and education aspects of diabetes to more rapidly improve the quality of life of those living with diabetes. In these past ten years, we've accelerated our basic research efforts and have aggressively pursued promising clinical research to help generate new treatments for this disease.

From UCSF School of Medicine Bridges curriculum, pioneering a new approach to medical education to prepare physicians for practice in the 21st century, Allison Xu discusses the biology behind obesity.

Premature senescent beta cells during the development of Type 1 diabetes